ND

Nakhrai Debbarma

Active Director Managing Director DIN 08278034
DIN 08278034 First appointment Nov 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Nakhrai Debbarma

Data last updated:

Nakhrai Debbarma is a Managing Director at Ludeb Pharmaceutical Private Limited (since 2018). The company operates in Pharma.

DIN 08278034
Primary Designation Managing Director
Industry Pharma
First Appointment 13 Nov 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ludeb Pharmaceutical Private Limited U85320TG2018PTC128257
Managing Director13 Nov 20182018Under Process Of Striking Off

Board colleagues of Nakhrai Debbarma

NameDINCompanyDesignation
Amita Debbarma08278035Ludeb Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ludeb Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Nakhrai Debbarma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nakhrai Debbarma

Nakhrai Debbarma currently holds 1 directorship: Ludeb Pharmaceutical Private Limited (Managing Director, since 13 Nov 2018).

Nakhrai Debbarma was first appointed on 13 Nov 2018 as Managing Director at Ludeb Pharmaceutical Private Limited.

The current boards of Nakhrai Debbarma's companies include Amita Debbarma (Ludeb Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available